- Home
- AOUT vs CHRS Comparison
AOUT vs CHRS Comparison
Compare AOUT & CHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AOUT
- CHRS
- Stock Information
- Founded
- AOUT 2020
- CHRS 2010
- Country
- AOUT United States
- CHRS United States
- Employees
- AOUT N/A
- CHRS N/A
- Industry
- AOUT Ordnance And Accessories
- CHRS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AOUT Industrials
- CHRS Health Care
- Exchange
- AOUT Nasdaq
- CHRS Nasdaq
- Market Cap
- AOUT 154.1M
- CHRS 84.2M
- IPO Year
- AOUT N/A
- CHRS 2014
- Fundamental
- Price
- AOUT $10.47
- CHRS $0.73
- Analyst Decision
- AOUT Strong Buy
- CHRS Buy
- Analyst Count
- AOUT 2
- CHRS 3
- Target Price
- AOUT $15.00
- CHRS $4.68
- AVG Volume (30 Days)
- AOUT 181.0K
- CHRS 1.3M
- Earning Date
- AOUT 06-26-2025
- CHRS 08-07-2025
- Dividend Yield
- AOUT N/A
- CHRS N/A
- EPS Growth
- AOUT N/A
- CHRS N/A
- EPS
- AOUT N/A
- CHRS N/A
- Revenue
- AOUT $222,322,000.00
- CHRS $272,251,000.00
- Revenue This Year
- AOUT $2.15
- CHRS N/A
- Revenue Next Year
- AOUT $6.36
- CHRS $106.56
- P/E Ratio
- AOUT N/A
- CHRS N/A
- Revenue Growth
- AOUT 10.55
- CHRS 19.87
- 52 Week Low
- AOUT $8.10
- CHRS $0.66
- 52 Week High
- AOUT $17.91
- CHRS $2.43
- Technical
- Relative Strength Index (RSI)
- AOUT 55.34
- CHRS 41.45
- Support Level
- AOUT $10.15
- CHRS $0.72
- Resistance Level
- AOUT $12.13
- CHRS $0.77
- Average True Range (ATR)
- AOUT 0.55
- CHRS 0.04
- MACD
- AOUT 0.00
- CHRS 0.00
- Stochastic Oscillator
- AOUT 81.86
- CHRS 13.65
About AOUT American Outdoor Brands Inc.
American Outdoor Brands Inc is engaged in the business of providing outdoor products and accessories for hunting, fishing, camping, shooting, and personal security and defense products. The company designs and produces products and accessories, including shooting supplies, rest, vaults, and other related accessories; premium sportsman knives and tools for fishing and hunting; land management tools for hunting preparedness; harvesting products for post-hunt or post-fishing activities; electro-optical devices, including hunting optics, firearm aiming devices, flashlights, and laser grips; reloading, gunsmithing, and firearm cleaning supplies; and survival, camping, and emergency preparedness products.
About CHRS Coherus BioSciences Inc.
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.